Risk adjusted net present value: What is the current valuation of Incyte’s Epacadostat?
Epacadostat is a small molecule commercialized by Incyte, with a leading Phase II program in Salivary Gland Cancer.
Epacadostat is a small molecule commercialized by Incyte, with a leading Phase II program in Salivary Gland Cancer.
What's Your Reaction?
